Inspire Medical Systems

Inspire Medical Systems EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Inspire Medical Systems (INSP) as of Nov 1, 2026 is 5.62 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 4.46 % — a change of 25.82% (higher).

EBIT/Assets

5.62 %

YoY

25.82%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Inspire Medical Systems is 2025 5.62 % . Operating Income to Assets Ratio (EBIT/Assets) of Inspire Medical Systems was 2024 4.46 % . It decreases by 25.82% higher compared to the previous year.

The Inspire Medical Systems EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-10.19 USD
Jan 1, 2019
-19.25 USD
Jan 1, 2020
-19.94 USD
Jan 1, 2021
-13.54 USD
Jan 1, 2022
-8.43 USD
Jan 1, 2023
-5.95 USD
Jan 1, 2024
4.46 USD
Jan 1, 2025
5.62 USD
The Inspire Medical Systems EBIT/Assets history
YEAREBIT/AssetsYoY
5.62 %+25.82%
4.46 %-175.02%
-5.95 %-29.38%
-8.43 %-37.80%
-13.54 %-32.07%
-19.94 %+3.56%
-19.25 %+88.89%
-10.19 %-83.98%
-63.61 %-51.72%
-131.76 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspire Medical Systems Stock analysis

What does Inspire Medical Systems do? Inspire Medical Systems Inc. is an American medical technology company that was founded in 2007 in Maple Grove, Minnesota. It focuses primarily on the development and production of implantable medical devices used in the treatment of sleep apnea. The company's business model is based on manufacturing and selling implantable devices, which are used by specially trained doctors. Inspire offers a comprehensive training program to educate doctors on the use of their devices and ensure optimal patient treatment. The company has had an impressive success story since its founding, with significant investments in research and development and the attainment of several patents. In summary, Inspire Medical Systems Inc. is an innovative company dedicated to the development and production of implantable medical devices for the treatment of sleep apnea. Its wide range of products and services aim to support doctors and patients, and the company is on track to become a leading provider in the industry. Inspire Medical Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspire Medical Systems stock

Operating Income to Assets Ratio (EBIT/Assets) of Inspire Medical Systems is 5.62 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Inspire Medical Systems changed from 4.46 % to 5.62 %, representing a 25.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Inspire Medical Systems since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Inspire Medical Systems with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Inspire Medical Systems

All Key Metrics — Inspire Medical Systems